PALMITAMIDE

Details

Stereochemistry	ACHIRAL
Molecular Formula	C16H33NO
Molecular Weight	255.4393
Optical Activity	NONE
Defined Stereocenters	0 / 0
E/Z Centers	0
Charge	0

SHOW SMILES / InChI

SMILES

CCCCCCCCCCCCCCCC(N)=O

InChI

InChIKey=HSEMFIZWXHQJAE-UHFFFAOYSA-N

InChI=1S/C16H33NO/c1-2-3-4-5-6-7-8-9-10-11-12-13-14-15-16(17)18/h2-15H2,1H3,(H2,17,18)

HIDE SMILES / InChI

Description

Palmitic acid amide (or palmitamide) is a primary fatty acid amide which was studied as a marker of the following diseases: schizophrenia and major depressive disorder.

Approval Year

Conditions

Conditions

Condition	Modality	Targets	Highest Phase	Product
Schizophrenia 298	Diagnostic		Natural Metabolite	Unknown
Major depressive disorder 173	Diagnostic		Natural Metabolite	Unknown

PubMed

Show entries

Title	Date	PubMed
Method for determination of fatty acid amides in polyethylene packaging materials--gas chromatography/mass spectrometry.	2009 Nov 27	19857868
Functional role of cannabinoid receptors in urinary bladder.	2010 Jan-Mar	20535281

Showing 1 to 2 of 2 entries

Previous1Next

Patents

Sample Use Guides

In Vivo Use Guide

Unknown

Route of Administration: Unknown

In Vitro Use Guide

Unknown

Show entries

Name

Type

Language

PALMITAMIDE

Official Name

English

CETYL AMIDE

Systematic Name

English

PALMITIC ACID AMIDE

Systematic Name

English

PALMITAMIDE (PALMITIC ACID AMIDE)

Common Name

English

HEXADECANAMIDE

Systematic Name

English

Showing 1 to 5 of 7 entries

Previous1 2Next

Show entries

Classification Tree

Code System

Code

Subpart B--Specific Prior-Sanctioned Food Ingredients

CFR

21 CFR 181.28

Showing 1 to 1 of 1 entries

Previous1Next

Show entries

Code System

Code

Type

Description

DAILYMED

QX1MQ82M73

PRIMARY

EPA CompTox

DTXSID8044707

PRIMARY

FDA UNII

QX1MQ82M73

PRIMARY

CAS

629-54-9

PRIMARY

RXCUI

159085

PRIMARY

RxNorm

Showing 1 to 5 of 9 entries

Previous1 2Next

SUBSTANCE RECORD


					QX1MQ82M73

PALMITAMIDE